Recursion Pharmaceuticals, Inc. is advancing REC-1245, an RBM39 degrader, in the DHALIA trial in solid tumors. Read more on ...

Yuandong Tian, who spent more than a decade as a research scientist director inside Meta’s Fundamental AI Research lab, has ...

Anthropic co-founder Jack Clark said AI agents might soon be able to build and train models themselves and, if that happens, ...

The maker of Claude wants the world to keep one option open. The timing is the tell.

Anthropic's research suggests AI is increasingly used to develop and improve new AI systems, with Claude now writing over 80% ...

Anthropic wants AI labs to prepare a global pause plan if advanced AI risks rise. Here’s what it means for South Africa.

Two new breakthroughs show how hard it is to know when the world has changed.

Anthropic quietly rationed the one domain where AI compounds fastest. Its fix made the fence visible, but didn't move it.

This week’s record SpaceX IPO captured the euphoria — and made Elon Musk the world’s first trillionaire; yet all the while, ...

As competition among AI companies intensifies, Anthropic is urging policymakers and researchers to consider how the world ...

A man raises his phone as police move into a crowd. The video is shaky, loud, immediate.